FR2337554B1 - - Google Patents

Info

Publication number
FR2337554B1
FR2337554B1 FR7600290A FR7600290A FR2337554B1 FR 2337554 B1 FR2337554 B1 FR 2337554B1 FR 7600290 A FR7600290 A FR 7600290A FR 7600290 A FR7600290 A FR 7600290A FR 2337554 B1 FR2337554 B1 FR 2337554B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7600290A
Other languages
French (fr)
Other versions
FR2337554A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR7600290A priority Critical patent/FR2337554A1/fr
Publication of FR2337554A1 publication Critical patent/FR2337554A1/fr
Application granted granted Critical
Publication of FR2337554B1 publication Critical patent/FR2337554B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/50—Nitrogen atoms bound to hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/28—Two oxygen or sulfur atoms
    • C07D231/30—Two oxygen or sulfur atoms attached in positions 3 and 5
    • C07D231/32—Oxygen atoms
    • C07D231/34—Oxygen atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached in position 4
FR7600290A 1976-01-08 1976-01-08 Nouveaux derives de la pyrazolidinedione Granted FR2337554A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7600290A FR2337554A1 (fr) 1976-01-08 1976-01-08 Nouveaux derives de la pyrazolidinedione

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7600290A FR2337554A1 (fr) 1976-01-08 1976-01-08 Nouveaux derives de la pyrazolidinedione

Publications (2)

Publication Number Publication Date
FR2337554A1 FR2337554A1 (fr) 1977-08-05
FR2337554B1 true FR2337554B1 (ja) 1978-11-03

Family

ID=9167689

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7600290A Granted FR2337554A1 (fr) 1976-01-08 1976-01-08 Nouveaux derives de la pyrazolidinedione

Country Status (1)

Country Link
FR (1) FR2337554A1 (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7279576B2 (en) 2002-12-31 2007-10-09 Deciphera Pharmaceuticals, Llc Anti-cancer medicaments
US7202257B2 (en) 2003-12-24 2007-04-10 Deciphera Pharmaceuticals, Llc Anti-inflammatory medicaments
US7144911B2 (en) 2002-12-31 2006-12-05 Deciphera Pharmaceuticals Llc Anti-inflammatory medicaments
WO2006071940A2 (en) 2004-12-23 2006-07-06 Deciphera Pharmaceuticals, Llc Enzyme modulators and treatments
US8188113B2 (en) 2006-09-14 2012-05-29 Deciphera Pharmaceuticals, Inc. Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
US7790756B2 (en) 2006-10-11 2010-09-07 Deciphera Pharmaceuticals, Llc Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
JP2010524970A (ja) 2007-04-20 2010-07-22 デシフェラ ファーマシューティカルズ，エルエルシー 骨髄増殖性疾患及びその他の増殖性疾患の治療に有用なキナーゼ阻害剤
BRPI0920765A2 (pt) 2008-10-29 2015-08-18 Deciphera Pharmaceuticals Llc Amidas de cilopropano e análogos que exibem atividades anticâncer e antiproliferativas
US8461179B1 (en) 2012-06-07 2013-06-11 Deciphera Pharmaceuticals, Llc Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
TW202122082A (zh) 2019-08-12 2021-06-16 美商迪賽孚爾製藥有限公司 治療胃腸道基質瘤方法
CA3150433A1 (en) 2019-08-12 2021-02-18 Deciphera Pharmaceuticals, Llc Ripretinib for treating gastrointestinal stromal tumors
FI4084778T3 (fi) 2019-12-30 2023-12-18 Deciphera Pharmaceuticals Llc Amorfisia kinaasi-inhibiittoriformulaatioita ja menetelmiä niiden käyttämiseksi
CA3163051A1 (en) 2019-12-30 2021-07-08 Michael D. Kaufman Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea
US11779572B1 (en) 2022-09-02 2023-10-10 Deciphera Pharmaceuticals, Llc Methods of treating gastrointestinal stromal tumors

Also Published As

Publication number Publication date
FR2337554A1 (fr) 1977-08-05

Similar Documents

Publication Publication Date Title
DE2657860C2 (ja)
FR2337554B1 (ja)
FR2445682B2 (ja)
JPS5441115Y2 (ja)
JPS5530850B2 (ja)
JPS52108644U (ja)
DE2648027C3 (ja)
JPS5337285U (ja)
CS178347B1 (ja)
JPS52123198U (ja)
CS177783B1 (ja)
CS177799B1 (ja)
JPS5387099U (ja)
JPS52108241U (ja)
CS178370B1 (ja)
CS175527B1 (ja)
JPS52170891U (ja)
JPS5295082U (ja)
JPS5322809U (ja)
JPS5326164U (ja)
JPS5366961U (ja)
JPS5374992U (ja)
CH605109A5 (ja)
CH603262A5 (ja)
CH599772A5 (ja)

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse